1Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study[J]. Am J.Epidemiol, 1985,121 ( 1 ) : 11 - 18.
2Visy JM, Je- Coz P,Chadefaux B,et al. Homocystinuria due to 5,10 - methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings[J]. Neurology, 1991,41:1313 - 1315.
3Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heartdisease : the Framinggham Study[ J ]. J Clin Epidemiol, 1988,41(3) :237.
4Kuwano K, Lkeda H, Oda T,et al. Xanthine oxidase mediates cyclic flow variation in a canine model of coronarial artery thrombosis[J]. Am J Physiol, 1996,270 : 1993 - 1999 .
5Nieto FJ,Iribarren C,Gvoss MD,et al. Uric acid and serum antioxidant capacity: a reaction to athemoclerosis [ J ]? Atherosclerosis,2000,148:131 - 139.
6Freedman DS, Williamson DF,Gunter EW,et al. Relation of serum uric acid to mortality and isehemic heart disease. The NHANES1 Epidemiologic Follow - up Study[J]. Am J Epidemiol, 1995,141 (7) :637 - 644.
7Tseng CH. Independent association of uric acid levels with peripheral arterial disease in Taiwan Residents patients with Type 2 diabetes [ J ]. Diabet Med, 2004,21 (7) :724 - 729.
8Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003,26 (1) : S5 - 20.
